|
Portfolio Companies
Xhale, Inc.
 Xhale is a medical technology company developing patented point-of-care/point-of-need medical diagnostics based on exhaled breath.
Exhaled breath is a unique bodily fluid, with previously unrecognized qualities that allow it to be used to determine correlated levels of various blood-borne compounds, substances, metabolites and blood constituents. Xhale is developing breath-based diagnostic and testing devices that will allow instantaneous real-time replacement for blood and urine tests. Applications for the company's technologies span the medical, home, law enforcement and industrial diagnostic markets.
The company's initial planned product lines include:
- Breath-Based Systems for Medication Monitoring & Adherence
- Breath-Based Consumer Diabetes Monitor
With patented and patent-pending technologies in these and numerous pipeline markets, Xhale Diagnostics is committed to bringing accurate, real-time, point of care/point-of-need diagnostic devices to the market, replacing or supplementing blood, urine or saliva-based tests, in the $28 billion diagnostic and testing market.
http://www.xhale.com/
|
